NBS

NeoStem, Inc. (NBS)

(MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NBS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2015/07/28	21 : 20	Dow Jones News	Diageo Terminates Heineken Partnership in South Africa	NASDAQ:NBS	Namibia Breweries Ltd.
2015/06/09	05 : 07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:NBS	(MM)
2015/06/09	05 : 05	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:NBS	(MM)
2015/06/06	05 : 21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NBS	(MM)
2015/05/29	21 : 26	GlobeNewswire Inc.	NeoStem Announces Plans to Change Name to Caladrius Biosciences Reflecting Transformation Into Immunotherapy Company	NASDAQ:NBS	(MM)
2015/05/29	19 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NBS	(MM)
2015/05/29	06 : 15	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NASDAQ:NBS	(MM)
2015/05/28	07 : 53	GlobeNewswire Inc.	NeoStem Prices $25,000,000 Public Offering of Common Stock	NASDAQ:NBS	(MM)
2015/05/28	06 : 17	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NASDAQ:NBS	(MM)
2015/05/28	06 : 10	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:NBS	(MM)
2015/05/28	05 : 01	GlobeNewswire Inc.	NeoStem Announces Proposed Public Offering of Common Stock	NASDAQ:NBS	(MM)
2015/05/26	20 : 30	GlobeNewswire Inc.	NeoStem Announces Dr. Merrick Ross of MD Anderson Cancer Center as Lead Principal Investigator for Pivotal Phase 3 Trial for ...	NASDAQ:NBS	(MM)
2015/05/22	04 : 03	GlobeNewswire Inc.	Turning Cancer Against Itself: Major Grant Advances Pioneering Melanoma Therapy at NeoStem	NASDAQ:NBS	(MM)
2015/05/06	19 : 08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NBS	(MM)
2015/05/06	19 : 01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:NBS	(MM)
2015/05/05	20 : 30	GlobeNewswire Inc.	NeoStem, Inc. Announces 2015 First Quarter Financial Results and Provides Corporate Update	NASDAQ:NBS	(MM)
2015/05/04	20 : 30	GlobeNewswire Inc.	NeoStem to Present at Multiple May and June Conferences	NASDAQ:NBS	(MM)
2015/04/30	05 : 01	GlobeNewswire Inc.	NeoStem Announces First Patient Randomized in Pivotal Phase 3 Melanoma Immunotherapy Clinical Trial	NASDAQ:NBS	(MM)
2015/04/29	21 : 30	PR Newswire (US)	Cryoport Supports NeoStem's Intus Study for the Treatment of Metastatic Melanoma	NASDAQ:NBS	(MM)
2015/04/27	20 : 30	GlobeNewswire Inc.	NeoStem's Lead Immuno-Oncology Product Candidate, NBS20, Receives ATMP Classification From the European Medicines Agency	NASDAQ:NBS	(MM)
2015/04/20	20 : 30	GlobeNewswire Inc.	NeoStem Announces Expanded Cell Therapy Manufacturing Relationship With Kite Pharma	NASDAQ:NBS	(MM)
2015/04/09	20 : 30	GlobeNewswire Inc.	NeoStem Announces Extension of Study Under Grant From California Institute of Regenerative Medicine (CIRM) to Fund Research o...	NASDAQ:NBS	(MM)
2015/04/06	20 : 30	GlobeNewswire Inc.	NeoStem to Present at Multiple April Conferences	NASDAQ:NBS	(MM)
2015/03/16	19 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NBS	(MM)
2015/03/16	19 : 00	GlobeNewswire Inc.	NeoStem Announces PreSERVE AMI Clinical Trial One-Year Follow-Up Results	NASDAQ:NBS	(MM)
2015/03/12	20 : 30	GlobeNewswire Inc.	NeoStem to Present at Two Upcoming Investor Conferences in March	NASDAQ:NBS	(MM)
2015/03/05	21 : 30	GlobeNewswire Inc.	NeoStem PreSERVE AMI Clinical Trial One-Year Results to be Presented at American College of Cardiology Annual Scientific Sess...	NASDAQ:NBS	(MM)
2015/03/03	06 : 01	GlobeNewswire Inc.	NeoStem, Inc. Announces 2014 Year-End Financial Results and Provides Corporate Update	NASDAQ:NBS	(MM)
2015/01/23	07 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NBS	(MM)
2015/01/17	06 : 35	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NBS	(MM)